Global map > Innovations > Middle East > Israel > Tel Aviv-Yafo > Bonus BioGroup
Bonus BioGroup icon
Bonus BioGroup initiated a preclinical study (“the Study”) of a unique drug product termed MesenCure, specially developed by the Company for the treatment of acute and life-threatening respiratory distress in coronavirus (COVID-19) and pneumonia patients.
Rankings by SemRush
National Ranking
33rd
in Israel
Regional Ranking
49th
in Middle East
Global Ranking
1427th
worldwide
Loading startups...